MannKind Corporation to Hold Fourth Quarter Financial Results Conference Call
on March 4, 2008
VALENCIA, Calif., Feb. 28 /PRNewswire-FirstCall/ -- MannKind Corporation
(Nasdaq: MNKD) will release its 2007 fourth quarter financial results on
Tuesday, March 4, 2008 at 7:00 a.m. ET.
Management of the Company will host a conference call to discuss the
fourth quarter financial results, clinical progress and other Company
developments at 9:00 a.m. ET on Tuesday, March 4, 2008. Presenting from the
Company will be its Chairman and Chief Executive Officer, Alfred Mann;
President and Chief Operating Officer, Hakan Edstrom; Corporate Vice President
and Chief Financial Officer, Dick Anderson and Corporate Vice President and
Chief Scientific Officer, Peter Richardson.
To participate in the live call by telephone, please dial (888) 566-5775
or (210) 234-0004. Those interested in listening to the conference call live
via the Internet may do so by visiting the Company's website at
http://www.mannkindcorp.com.
A telephone replay of the call will be accessible for approximately
fourteen days following completion of the call by dialing (866) 396-7637 or
(203) 369-0522. A replay will also be available on MannKind's website for
fourteen days.
About MannKind Corporation
MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development
and commercialization of therapeutic products for diseases such as diabetes
and cancer. Its lead product, the Technosphere(R) Insulin System, is
currently in Phase 3 clinical trials in the United States, Europe and Latin
America to study its safety and efficacy in the treatment of diabetes. For
more information on MannKind Corporation and its technology, visit
http://www.mannkindcorp.com.
SOURCE MannKind Corporation
Dick Anderson, Chief Financial Officer of MannKind Corporation,
+1-661-775-5302, danderson@mannkindcorp.com
